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Amelogenesis imperfecta (AI) is the name given to a heterogeneous group of conditions
characterized by inherited developmental enamel defects. AI enamel is abnormally thin,
soft, fragile, pitted and/or badly discolored, with poor function and aesthetics, causing
patients problems such as early tooth loss, severe embarrassment, eating difficulties,
and pain. It was first described separately from diseases of dentine nearly 80 years ago,
but the underlying genetic and mechanistic basis of the condition is only now coming to
light. Mutations in the gene AMELX, encoding an extracellular matrix protein secreted by
ameloblasts during enamel formation, were first identified as a cause of AI in 1991. Since
then, mutations in at least eighteen genes have been shown to cause AI presenting in
isolation of other health problems, with many more implicated in syndromic AI. Some
of the encoded proteins have well documented roles in amelogenesis, acting as enamel
matrix proteins or the proteases that degrade them, cell adhesion molecules or regulators
of calcium homeostasis. However, for others, function is less clear and further research
is needed to understand the pathways and processes essential for the development of
healthy enamel. Here, we review the genes and mutations underlying AI presenting in
isolation of other health problems, the proteins they encode and knowledge of their roles
in amelogenesis, combining evidence from human phenotypes, inheritance patterns,
mouse models, and in vitro studies. An LOVD resource (http://dna2.leeds.ac.uk/LOVD/)
containing all published gene mutations for AI presenting in isolation of other health
problems is described. We use this resource to identify trends in the genes andmutations
reported to cause AI in the 270 families for which molecular diagnoses have been
reported by 23rd May 2017. Finally we discuss the potential value of the translation of AI
genetics to clinical care with improved patient pathways and speculate on the possibility
of novel treatments and prevention strategies for AI.
Keywords: amelogenesis, amelogenesis imperfecta, ameloblasts, enamel, biomineralization, Leiden Open Variant
Database, LOVD, amelogenesis genetics
INTRODUCTION
Mature enamel is the hardest, most mineralized tissue in the human body, comprising >95% by
weight crystals of substituted calcium hydroxyapatite (HA; Ca10[PO4]6[OH]2). Enamel consists
of a highly organized structure of interwoven prisms and inter-prismatic material, both made
up of HA crystals (Figure 1). This structural organization and chemical composition provide the
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FIGURE 1 | Ameloblast morphology, crystal development, and the final structure of the enamel. (A) Schematic cross section of the murine incisor. (B–D) Histology of
the murine incisor. (B) During secretion, ameloblasts exhibit an elongated morphology with a cellular extension (the Tomes’ process); (C) during transition the Tomes’
process degenerates and the ameloblasts begin to reduce in height; (D) during maturation, the ameloblasts remove nearly all protein from the developing enamel and
supply mineral ions to support crystallite growth; (E) immature enamel crystalites form during secretion by growth in their long axis; (F) by the end of secretion, the
developing enamel is around 30% mineral and 25% matrix protein, with the remainder tissue fluid. By the end of maturation, the enamel is nearly 100% mineral; (G)
the enamel crystallites grow in width and thickness during enamel maturation; (H) and (I) murine enamel has a decussating arrangement of enamel prisms; (J) and (K)
human enamel is also arranged in a prismatic structure. Elements from this figure have been adapted from previously published figures and we acknowledge the
following publications and publishers for the elements specified: Panels (A–D) were previously published by Barron et al. (2010). Panel (E) was previously published by
Robinson (2014).
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mechanical strength to withstand long-term use. The enamel-
forming cells, the ameloblasts, are lost upon tooth eruption.
Consequently enamel lacks any capacity for cellular repair and
once formed, must function over a lifetime.
Amelogenesis
Amelogenesis is the process of enamel formation. It takes place
in three, well-defined stages known as the secretory, transition
and maturation phases (Figure 1). The initial differentiation,
positioning and orientation of ameloblasts, as well as their
coordinated functioning as a cohort, are also crucial to
amelogenesis.
Amelogenesis involves the secretion of a proteinaceous matrix
in which immature enamel HA crystallites are deposited. The
matrix is then degraded and concurrently replaced, almost
entirely, with HA mineral (Figure 2). During the secretary
phase, the ameloblasts move away from the dentino-enamel
junction (DEJ), secreting a soft extracellular protein matrix by
exocytosis from cellular extensions (known as Tomes’ processes)
to fill the space they leave behind (Skobe, 1976). During
the transition stage, which begins as the matrix achieves the
thickness of the future enamel, matrix protein secretion decreases
and the ameloblasts restructure (Reith, 1970). During the
maturation stage, the matrix proteins are degraded by proteases
and replaced with tissue fluid. Maturation stage ameloblasts
increase their active transport of mineral ions into the fluid,
which drives the growth of the pre-existing enamel crystallites
in width and thickness (Robinson et al., 1995). During this
stage, ameloblasts alternate between a ruﬄe ended and smooth
ended morphology in groups of coordinated cells (Warshawsky
and Smith, 1974). These different morphologies reflect cyclical
changes in ameloblast function related to the regulation of pH
and the control of ion transport so that the enamel becomes
progressively more mineralized until the crystallites occlude the
tissue volume. Thematrix is transformed intomature enamel that
is almost devoid of protein (Smith, 1998).
Throughout the transition andmaturation stages, around 50%
of the ameloblasts undergo apoptosis (Smith and Warshawsky,
1977). Post maturation, the surviving ameloblasts either apoptose
or go on to contribute to the junctional epithelium of mature
teeth (Bosshardt and Lang, 2005).
Amelogenesis Imperfecta
Definition and Phenotypes
Amelogenesis imperfecta (AI) is a heterogeneous group of
genetic conditions characterized by defects in the formation of
enamel in all teeth of both dentitions. In an effort to classify
the disease, particular phenotypes have been defined but this
approach can be confounded by mixed phenotypes (Figure 3).
Hypoplastic AI describes thin but mineralized enamel, or in
extreme cases, the complete absence of enamel, that results from
failure during the secretory stage. Hypomineralized AI is caused
by maturation stage failure, giving rise to enamel that is of full
thickness but is weak and fails prematurely. The hypomineralized
phenotype can be further subdivided into hypomaturation and
hypocalcified AI. The former is caused by incomplete removal
of protein from the enamel matrix and produces brittle enamel,
while the latter is characterized by insufficient transport of
calcium ions (Ca2+) into the developing enamel and produces
soft enamel.
Phenotyping of teeth from AI patients is complicated by
post-eruptive changes that occur during the time spent in the
mouth. Obtaining unerupted genotyped human embryonic teeth
would be difficult and ethically questionable, while the study of
erupted teeth precludes the direct study of amelogenesis (though
enamel composition and ultrastructure can provide some form of
record of the events occurring during amelogenesis). Therefore,
mouse models have proved invaluable to AI research. Murine
phenotyping of AI disease models can utilize the continuously
erupting incisor to view all stages of amelogenesis at once, or gain
a snapshot of amelogenesis via analysis of embryonic/neonatal
unerupted molar teeth. Figure 1 shows the histology of the
murine incisor and Supplementary Table 1 summarizes a
selection of the AI-relevant mouse models that have been well
characterized to date. The table also highlights genes for which
murine models have not yet been described or for which an
abnormal dental phenotype has not been reported.
Prevalence, Impact, and Treatment
AI is reported to range in frequency in different populations from
1 in 700 to 1 in 14,000 (Witkop and Sauk, 1976; Backman and
Holm, 1986; Crawford et al., 2007), and has a significant impact
upon patients and healthcare provision (Coffield et al., 2005). AI
enamel is abnormally thin, soft, fragile, pitted and/or discolored,
causing patients severe embarrassment, eating difficulties and
pain. It is also associated with negative social outcomes and poor
aesthetics (Hashem et al., 2013). AI is very difficult to treat and
there is a weak evidence base to inform clinical decision-making
and management choices (Dashash et al., 2013). Interventions
focus on aesthetics and maintaining occlusal height and tooth
function, whilst maintaining the natural dentition for as long
as possible. Diagnostically it is necessary to distinguish AI from
more common enamel defects such as fluorosis, molar incisor
hypomineralization (Gotler and Ratson, 2010) and those caused
by time-limited events, such as serious systemic illness (Salanitri
and Seow, 2013).
THE GENETICS OF AMELOGENESIS
IMPERFECTA
AI was first described as a separate clinical entity to
dentinogenesis imperfecta in 1938 (Finn, 1938) and its
study has helped to define the processes and genes involved
in amelogenesis. Since the discovery, over 25 years ago, that
mutations in amelogenin, X linked (AMELX) lead to AI
(Lagerstrom et al., 1991), many other genes have been shown to
be defective in AI. The falling costs of next generation sequencing
(NGS) have accelerated the identification of new genes for AI.
These discoveries have also expanded the known functions of
proteins mutated in AI from solely the structural enamel matrix
proteins and their proteolytic processing enzymes, to a range
of other proteins, involved in diverse functions, such as vesicle
transport, pH sensing and cell adhesion.
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FIGURE 2 | Schematic diagram depicting the main events during amelogenesis. (A) Pre-secretory stage: Ameloblasts (blue) differentiate from the cells of the inner
enamel epithelium (IEE), in response to reciprocal signaling between the IEE and the dental papilla. The basal lamina between the IEE and dental papilla breaks down
so that the cells are in contact with the pre-dentine. The ameloblasts elongate and their nuclei shift to the proximal side of the cell, nearest the stratum intermedium
(SI), resulting in reversal of the ameloblasts’ polarity. At the distal end, closest to the pre-dentine, the Golgi apparatus and rough endoplasmic reticulum increase in size
to increase the capacity for protein production, post translational modification and secretion. The non-dividing cell becomes further polarized as it forms a distal
extension that will go on to form the Tomes’ process (TP). Each ameloblast develops and maintains anchoring junctions to hold the ameloblast layer in alignment and
to control what passes between them. (B–D) Secretory stage: During the secretory stage, a proteinaceous extracellular matrix is secreted from the ameloblast TP, as
the ameloblast layer retreats from the dentine layer. To achieve this, ameloblasts produce large amounts of membrane bound, secretory granules containing enamel
matrix proteins (EMPs). EMPs are constitutively secreted via exocytosis into the extracellular space at the distal end of the cell, on to the newly formed dentine.
(B) Mineral immediately forms in this initial enamel matrix and forms a close association with the dentine mineral. This will form the aprismatic enamel. (C) The
ameloblasts begin to move away from the dentine and further develop their TP at the distal end. EMPs are secreted from two aspects of the ameloblasts to produce
enamel matrix that will go on to form the prismatic and interprismatic enamel. (D) As secretion progresses the TP lengthens and thins. The portion secreting the
prismatic enamel is reduced before secretion ceases, therefore the final enamel formed will be aprismatic. (E) Transition stage: The transition stage is characterized by
reduced EMP secretion and internal reorganization of the ameloblasts. Ameloblasts shorten to around half their original height and reduce in volume. Their nuclei
become more central and the ER is reduced in size. The TP is completely lost and an atypical basal lamina is formed against the enamel matrix. Ameloblasts adhere to
the enamel matrix via hemidesmosomes. The cells of the SI, stellate reticulum and the outer enamel epithelium form the papillary layer (PL). Capillaries invaginate into
this layer and overlay the ameloblasts. The cells of the PL may assist ameloblasts in the maturation stage by participating in ion transport and removal of enamel
protein products and water from the developing enamel. The ameloblast population reduces by around 25% at this stage through apoptosis. (F) and (G) Maturation
stage: During the maturation stage the partially mineralized enamel matrix becomes fully mineralized by the breakdown and removal of residual EMPs, and the growth
in width and thickness of enamel crystallites. These processes are achieved through repeated cyclical processes. The ameloblasts act as a gated barrier for the
movement of ions and degraded proteins between the SI and the developing enamel and vice versa. To achieve this, the ameloblast membrane facing the enamel
matrix modulates between ruffle ended (F) and smooth ended (G) morphologies. This is achieved in coordinated groups of ameloblasts across the developing
enamel. Ruffle ended ameloblasts (RA) form membrane invaginations and tight junctions at the apical end, near the enamel surface, whereas smooth ended
ameloblasts (SA) are more leaky. Enamel crystal growth generates large amounts of protons but it has also been shown that protons are pumped into the enamel by
RA. Both RA and SA release bicarbonate ions into the enamel that act as a buffer to increase pH. A mildy acidic pH is found in enamel at RA regions and a more
(Continued)
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FIGURE 2 | Continued
neutral pH in SA regions. During maturation around 25% of ameloblasts apoptose. (H) Post-maturation stage: The ameloblasts and other cells of the enamel organ,
form the reduced enamel epithelium, which eventually contributes to the junctional epithelium of mature teeth. However, many of the ameloblasts apoptose before the
formation of the junction epithelium is completed.
FIGURE 3 | Clinical images that illustrate the variability of AI. (A) Hypoplastic AI is characterized by teeth without the curves associated with a normal enamel volume.
(B) In hypomaturation AI enamel volume can be near-normal, but opaque with structural weaknesses that result in rapid post-eruptive enamel loss with enamel
fracturing away to exposure the underlying dentine. (C) Brown discolouration and early post-eruptive enamel loss is typical of hypomineralised forms of AI. (D) Mixed
AI phenotypes are frequently encountered. In this example a near-normal enamel volume is characterized by multiple focal pits that are most evident on the inset
image, with variable colouration that includes focal opacities, but without premature fracturing of the enamel to reveal dentine.
Here we review advances in our understanding of the
molecular basis of AI presenting in isolation of other health
problems with recognition that co-segregating health problems
may present later in life. For some of the genes included,
other mutations can cause more widespread health problems
beyond AI. We focus on the more recently identified AI genes,
but include all reported genes, reviewing the functions of the
proteins that they encode, the mutations identified and the
resulting enamel phenotypes. We also summarize the murine
models available and document any enamel phenotypes observed
in these. Furthermore, we highlight a new online resource
(http://dna2.leeds.ac.uk/LOVD/), detailing nearly two hundred
published AI-causing mutations identified in two hundred and
seventy families reported by 23rd May 2017. This resource
represents an open repository for all interested in advancing the
understanding of amelogenesis.We conclude by considering how
these advances might impact on clinical care in future.
The Enamel Matrix Proteins
The first AI-causing mutations were identified in the genes
encoding the enamel matrix proteins (EMPs), known to make up
the bulk of the secreted enamel organic matrix. The EMP genes
evolved from a common ancestral gene (Sire et al., 2007) and
form part of the secretory calcium-binding phosphoprotein gene
cluster. Their encoded proteins have a distinctive architecture of
a signal peptide and a conserved casein kinase 2 phosphorylation
domain likely to be targeted by family with sequence similarity
20, member C (FAM20C, MIM ∗611061) (Yang et al., 2016).
The enamel matrix proteins include amelogenin (AMELX,
MIM ∗300391), which makes up around 90% of the EMPs
secreted by ameloblasts (Termine et al., 1980), with the remaining
10% comprising ameloblastin (AMBN, MIM ∗610259) and
enamelin (ENAMMIM ∗606585), in order of abundance (Smith,
1998). The alternative splicing and extracellular proteolytic
processing of amelogenin, ameloblastin and enamelin have been
reviewed elsewhere (Brookes et al., 1995; Iwata et al., 2007;
Kobayashi et al., 2007; Moradian-Oldak, 2012). However, it is
becoming increasingly clear that it is not only perturbation of
the proteins’ extracellular roles as part of the enamel matrix that
is important in AI, but also the proteins’ aberrant intracellular
processing and the outcome of the unfolded protein response
(UPR; Brookes et al., 2014).
AMELX
Amelogenin is a hydrophobic, proline and histidine rich protein,
thought to act as an enamel matrix pH buffer (Guo et al., 2015)
and as a scaffold for the spacing and growth of enamel crystallites
(Chen et al., 2011). It is subject to extensive extracellular
proteolytic processing following its secretion (Brookes et al.,
1995). It is regarded as a tooth specific protein since it has not
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been detected elsewhere in human tissues (Chan et al., 2011).
However, in murine tissues, it has been detected in dentine-
forming, cementum-forming and bone-forming cells, as well as
in the developing eye and brain (Fong and Hammarstrom, 2000;
Janones et al., 2005; Haze et al., 2007).
AMELX mutations cause X-linked AI (MIM #301200)
(Lagerstrom et al., 1991). Heterozygous mutations tend to
present in female AI patients as stripes of normal and AI affected
enamel due to lyonization (Berkman and Singer, 1971). In males,
a copy of AMELX exists as AMELY on the Y chromosome, but
AMELY transcription is around 10% of that of AMELX (Aldred
et al., 1992; Salido et al., 1992) and hence cannot compensate
for loss of AMELX expression. The AI phenotype in males is
determined by the type and position of the mutation. Large
deletions and N-terminal variants cause a hypomaturation AI
defect with variable focal hypoplasia while mutations in the signal
peptide and toward the C terminus cause smooth hypoplastic AI
(Hart et al., 2002).
Over twentyAMELXmutations have been reported, including
large deletions, frameshifts, nonsense and missense variants. For
the majority of variants, pathology is thought to be due to loss
of function, though an Amelx mutation in mice has been linked
to toxic gain of function via activation of the pro-apoptotic UPR
(Brookes et al., 2014). Altered splicing, due to variants such as
the silent c.120T>C (NM_182680.1) change, has also been shown
to result in enamel pathology (Cho et al., 2014). This particular
variant prevents the excision of exon 4 from the majority of
AMELX transcripts, thus preventing the formation of a miRNA
from the normally excised exon 4 (Le et al., 2016). These examples
show that further study, within the context ofAMELX alternative
splicing and its roles in signaling, is required to accurately define
disease mechanisms.
ENAM
Enamelin, the largest of the EMPs, is a tooth specific acidic
protein expressed primarily by secretory stage ameloblasts (Hu
and Yamakoshi, 2003). It is successively cleaved from its C
terminus, resulting in numerous products (Fukae et al., 1993;
Hu and Yamakoshi, 2003; Lu et al., 2008). Like amelogenin and
ameloblastin, the uncleaved protein is found only within the
newly secreted, outermost layer of the enamel matrix and is
thought to be involved in enamel crystal extension (Hu et al.,
2008). Some ENAM cleavage products, such as the 32 kDa
fragment identified in pigs, have high affinity for HA crystals
and accumulate within and between the enamel prisms (Hu and
Yamakoshi, 2003).
The first mutation identified in ENAM caused an autosomal
dominant AI with a severe, smooth hypoplastic phenotype
(MIM #104500) as a result of a dominant-negative effect of
aberrant splicing (Rajpar et al., 2001) and a milder, local
hypoplastic phenotype (MIM #204650) caused by missense
mutations (Mardh et al., 2002). Autosomal recessive inheritance
has also been documented for ENAM mutations (Hart et al.,
2003; Ozdemir et al., 2005a; Chan et al., 2010); homozygotes
and heterozygotes present with a severe and a milder, local form,
respectively (Ozdemir et al., 2005a). Severity based on zygosity is
more often seen with nonsense or frameshift variants that escape
nonsense mediated decay (NMD).
AMBN
AMBN is rich in glycine, leucine and proline and, in addition to
within the enamel matrix, localizes to the Tomes’ processes and
the DEJ (Krebsbach et al., 1996; MacDougall et al., 2000), but has
also been detected in pre-odontoblasts, developing tooth roots
and craniofacial bone (Fong et al., 1996, 1998; Spahr et al.,
2006). AMBN is expressed throughout amelogenesis (Lee et al.,
1996) but peaks during the secretory stage (Fukumoto et al.,
2004). AMBN transcripts undergo alternative splicing to form
two isoforms (Krebsbach et al., 1996; Hu et al., 1997). Porcine
ameloblastin is extensively modified and is cleaved upon
secretion by MMP20 to form a number of protein products
that accumulate within different compartments of the enamel
matrix. For example, N-terminal products accumulate between
the enamel prisms throughout the matrix (Bartlett and Simmer,
1999). Although, it is known that AMBN can influence the
differentiation and proliferation of ameloblasts (Fukumoto et al.,
2004), it is also important in extracellular signaling to induce
osteoblast differentiation (Iizuka et al., 2011), cell adhesion, via
heparin and fibronectin (Beyeler et al., 2010), and mineralization
(Yamakoshi et al., 2001; Zhang et al., 2011).
Only two mutations have been reported in AMBN in
AI patients, both discovered through NGS. The first AMBN
mutation reported, a large, in-frame deletion encompassing exon
6, segregated with recessive hypoplastic AI (MIM #616270)
in a consanguineous Costa Rican family (Poulter et al.,
2014c). Scanning electron microscopy showed both reduced
mineral density and enamel thickness, mirroring the murine
Ambn−5,6/−5,6 model. The second homozygous mutation,
thought to alter splicing, was identified in one patient in a
large cohort with oro-dental disease, using a targeted NGS assay
(Prasad et al., 2016a).
The Enamel Matrix Proteases
Another group of genes for which a candidate approach
identified AI-causing mutations are those encoding the
enamel matrix proteases. These enzymes include matrix
metallopeptidase 20 (MMP20, MIM ∗604629), which specifically
cleaves the enamel matrix proteins during the secretory stage to
produce functional peptides, and kallikrein related peptidase 4
(KLK4, MIM ∗603767) that proteolytically degrades the enamel
matrix proteins to facilitate their removal by endocytosis during
the maturation stage.
MMP20
Matrix metallopeptidases (MMPs) influence cell motility by
regulating cell interactions and matrix degradation, crucial
processes in many aspects of development (VanSaun and
Matrisian, 2006). Like other MMPs, MMP20 is a zinc dependent
endopeptidase that is secreted in an inactive precursor form that
requires cleavage for its activation (Llano et al., 1997). MMP20
is secreted by ameloblasts concurrent with the EMPs, and is
responsible for cleavage of EMP at specific residues, shortly
after their secretion (Simmer and Hu, 2002). This generates
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products with specific, diverse roles during amelogenesis.
MMP20 has been shown to be necessary for controlling HA
crystal morphology (Prajapati et al., 2016) and through its action
on amelogenin, may regulate mineralization (Kwak et al., 2016).
MMP20 is also capable of cleaving the extracellular domains of
cadherins that mediate cell-cell interactions as part of adherens
junctions to allow ameloblast cell movement (Guan and Bartlett,
2013; Guan et al., 2016). This may affect amelogenesis since
ameloblasts must move in synchronous groups in order to
form typical enamel architecture. Since cadherins are linked to
the actin cytoskeleton via catenins, cadherin cleavage releases
β-catenin, which can act as a transcription factor and may be
important for ameloblast differentiation (Bartlett et al., 2011;
Guan et al., 2016).
Mutations in MMP20 lead to autosomal recessive
hypomaturation AI (MIM #612529) (Kim et al., 2005). Eleven
missense, nonsense, frameshift and splice site mutations have
been described, all resulting in a similar phenotype (Ozdemir
et al., 2005b; Papagerakis et al., 2008; Lee et al., 2010a; Gasse
et al., 2013; Wang et al., 2013b). All five of the missense variants
reported lie within either the catalytic peptidase domain or the
hemopexin domain, which, through homology, is thought to
influence substrate specificity or to bind inhibitors or activators
of the pro-enzyme.
KLK4
KLK4 encodes a serine protease that is expressed and secreted
by ameloblasts in both the transition and maturation stages of
amelogenesis (Hu et al., 2000, 2002; Simmer et al., 2009). Like
MMP20, newly secreted KLK4 must be cleaved for its activation.
In vitro experiments have shown that MMP20 can activate newly
secreted KLK4 and that KLK4 can inactivate MMP20, potentially
explaining the shift in proteinase activity during the transition
stage (Yamakoshi et al., 2013).
KLK4 acts to further degrade the enamel proteins already
cleaved byMMP20 during secretion and is capable of functioning
over the wide pH range that occurs during maturation (Smith,
1998; Bartlett, 2013). Such activity aids removal of protein from
the developing enamel by maturation stage ameloblasts, allowing
the enamel crystallites to grow in width and thickness (Simmer
et al., 2009; Bartlett, 2013).
KLK4 mutations cause autosomal recessive hypomaturation
AI (Hart et al., 2004). All four KLK4 variants reported so far
are either nonsense or frameshift mutations (Hart et al., 2004;
Wright et al., 2011; Wang et al., 2013b; Smith et al., 2017a).
However, only two of the four are predicted to lead to NMD. Of
the two frameshift mutations affecting codons in the final exon,
and therefore not expected to undergo NMD, one alters one of
the three catalytic residues, p.S207, essential to the function of
all kallikrein enzymes. This mutation has been shown to result
in greatly reduced protein expression and proteolytic function
(Seymen et al., 2015). Prior to the identification of the frameshift
variant, c.632delT only three KLK4 variants in four families
had been identified. However, the c.632delT variant, reported to
occur at a frequency of 0.15% in the South Asian population,
has been reported in five Pakistani families with hypomaturation
AI and is predicted to disrupt three of six structurally important
disulphide bonds (Smith et al., 2017a). Characterization of the
human enamel phenotype revealed that overall the enamel was
hypomineralized but that the deeper (inner) enamel was more
seriously affected than themore superficial (outer) enamel (Smith
et al., 2017a).
Cell-Cell and Cell-Matrix Adhesion
For amelogenesis to proceed, the ameloblasts must function
as a coordinated cohort and must maintain their contact
with the secreted extracellular matrix (ECM) not only as they
retreat from the dentine surface during secretion, but also
during transition and maturation. These contacts require specific
molecules, including integrins, laminins and collagens, and
structures such as desmosomes and hemidesmosomes. The basal
lamina degrades as the pre-ameloblasts undergo their terminal
differentiation and an atypical basal lamina is then reformed
during the transition stage. During the secretory stage, the
Tomes’ processes act as the contact point between the ameloblast
and the enamel matrix.
ITGB6
Integrin, β6 (ITGB6; MIM ∗147558) is a member of a large
family of cell surface-adhesion receptors that mediate cell-cell
and cell-ECM interactions by facilitating interaction with the
cytoskeleton (Alberts et al., 2002). ITGB6 is predominantly found
in epithelial cells and forms a heterodimer with integrin subunit
alpha V (Busk et al., 1992; Breuss et al., 1993). Within the
developing tooth, ITGB6 localizes predominantly in maturation
stage ameloblasts (Wang et al., 2014b).
ITGB6 is known to bind to arginine-glycine-aspartic acid
(RGD) motifs which are found in ECM proteins such as
fibronectin, as well as the latency associated peptide of
transforming growth factor-β1 (TGF-β1) (Breuss et al., 1993;
Weinacker et al., 1994; Munger et al., 1999; Annes et al., 2002).
Via this interaction and other mechanisms, ITGB6 is able to
activate TGF-β1 (Munger et al., 1999).
An Itgb6 null mouse exhibited a hypomineralized AI
phenotype, with the loss of any ordered enamel prism
arrangement (Mohazab et al., 2013). Accumulation of
amelogenin in the enamel matrix and the presence of enamel pits
were also noted (Mohazab et al., 2013). Patients with mutations
in ITGB6 have since been reported (MIM #616221) with either
hypomineralized pitted enamel, similar to that reported in
the Itgb6 null mouse (Poulter et al., 2014a), or hypoplastic
enamel with a rough surface (Wang et al., 2014b), both
recessively inherited. More recently, Ansar et al. (2015) reported
a consanguineous family with a homozygous ITGB6 mutation
with adolescent alopecia, intellectual disability and dentogingival
abnormalities with rough, discolored enamel. However, it is
unclear if these additional phenotypes result from the ITGB6
variant or are co-segregating, for example, due to an undetected
copy number variant. The ITGB6 missense mutations identified
so far lie within the β1 domain of the protein involved in binding
to α integrin subunits, activity-modifying cations and ligands
(Xiong et al., 2001, 2002). Wang et al. (2014b) also reported
a patient with a homozygous ITGB6 nonsense mutation, but
phenotyping of the enamel was complicated by the co-presence
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of a hemizygous Nance-Horan syndrome (congenital cataracts
and dental anomalies) mutation (MIM ∗300457).
LAMA3, LAMB3, and COL17A1
Laminin, alpha 3 (LAMA3; MIM ∗600805), laminin, beta 3
(LAMB3; MIM ∗150310) and laminin gamma 2 (LAMC2; MIM
∗150292) encode the three subunits of the heterotrimeric protein
laminin 332 (LM332), which localizes to epithelial basement
membranes of the ECM (Aberdam et al., 1994a). LM332 has a
central role in the assembly and stability of hemidesmosomes,
structures that mediate attachment between cells and the ECM
(Nievers et al., 1999). Collagen type XVII, alpha-1 (COL17A1;
MIM ∗113811) is a constituent of hemidesmosomes and is a
ligand for LM332 (Nishie et al., 2011; Van den Bergh et al.,
2011).Mutations in the genes encoding COL17A1 or the subunits
of LM332 cause the autosomal recessive condition junctional
epidermolysis bullosa (JEB; MIM #226700, #226650), in which
failure to form hemidesmosomes between skin layers leads to
extensive skin blistering (Aberdam et al., 1994b; Pulkkinen et al.,
1994a,b; Kivirikko et al., 1995; McGrath et al., 1995). In addition,
JEB patients often present with hypoplastic, pitted enamel
(Wright et al., 1993), and it has been noted that heterozygous
carriers of some mutations in these genes sometimes have AI in
the absence of any skin phenotype (McGrath et al., 1996; Yuen
et al., 2012; Kim et al., 2013; Poulter et al., 2014b).
LM332 has been implicated in ameloblast adhesion to the
enamel surface via interaction with integrin alpha 6 beta 4 within
hemidesmosomes; and in cell migration via binding of integrin
alpha 3 beta 1 (Carter et al., 1991; Marchisio et al., 1993).
Mature ameloblasts and Tomes’ processes show particularly
strong staining for mature LM332 protein (Yoshiba et al., 1998),
which is thought to participate in the control of ameloblast
differentiation and adhesion to the enamel matrix. This is
supported by analysis of tooth buds from JEB patients, which
show ameloblast disorganization and subsequent reduction in
enamel volume (Brain and Wigglesworth, 1968). Enamel in JEB
patients also has a number of changes in chemical composition,
suggesting that mineral transport or ameloblast metabolism is
affected (Kirkham et al., 2000).
No enamel phenotype has been reported for Lamb3 null mice
since they die in early post-natal life (Kuster et al., 1997). In
contrast, for Lama3 null mice, ameloblasts were smaller than
those in wild-type (WT) mice, suggesting that LM332 is required
for normal ameloblast differentiation (Ryan et al., 1999). Enamel
deposition was described as abnormal and the enamel epithelium
was disorganized (Ryan et al., 1999).
COL17A1 is expressed throughout enamel formation (Asaka
et al., 2009). Col17−/− mice have fewer hemidesmosomes than
WT mice and exhibit thin, disorganized Tomes’ processes
(Asaka et al., 2009). This may be the result of alterations
in ameloblast differentiation due to lack of contact with, and
signals from, mesenchymal tissues. Mineralization is delayed in
Col17−/− mice. The enamel formed lacks the typical regular
prism structure and the prisms themselves are malformed, a
phenotype reminiscent of the Lama3−/− mouse but not as severe
(Asaka et al., 2009). Enamel proteins such as AMELX, AMBN,
and ENAM are expressed by ameloblasts at a significantly lower
level in Col17−/− mice than WT, whereas expression of the
pre-secretory protein tuftelin is increased, again suggesting that
ameloblast differentiation is incomplete inCol17−/−mice (Asaka
et al., 2009).
Heterozygous carriers of some LAMA3, LAMB3, and
COL17A1mutations present with hypoplastic AI (MIM #104530)
(Murrell et al., 2007; Pasmooij et al., 2007; Yuen et al., 2012;
Kim et al., 2013; Poulter et al., 2014b). Initial reports of
the tooth phenotype simply mentioned that the relatives of
some JEB patients had poor enamel, without recognition that
the phenotype was truly AI (Murrell et al., 2007; Pasmooij
et al., 2007). It was not until later that families segregating AI
with autosomal dominant inheritance, and without any family
members with JEB, were recognized and the phenotype more
accurately described as AI (Poulter et al., 2014b).
The enamel of LAMA3 and LAMB3 patients is similarly
described as hypoplastic, with grooving and pitting often present
(Kim et al., 2013; Lee et al., 2014; Poulter et al., 2014b). Carriers
of the JEB-causing LAMA3 frameshift mutation c.488delG were
found to have rough, pitted enamel due to haploinsufficiency of
the protein (Yuen et al., 2012). One report of a patient carrying
a LAMB3mutation highlighted that the multi-cusped teeth were
more severely affected by AI than the anterior teeth (Kim et al.,
2016b), although further study is required to determine whether
this is a general trend.
AI-causing mutations in LAMA3 and LAMB3 present
somewhat of a dichotomy. LAMA3 variants that cause AI in
heterozygous carriers, also cause JEB in biallelic individuals
but the majority of AI-causing LAMB3 variants have not been
reported in JEB patients. Most LAMB3 variants identified in AI
patients are either frameshift or nonsense mutations predicted to
escape NMD. The variants are consistent with a dominant gain of
function disease mechanism, unlike the loss of function variants
associated with recessively inherited JEB. However, Prasad et al.
(2016a) did identify two AI patients carrying LAMB3 mutations
that do not fit this pattern of pathogenesis. These mutations have
also been identified in JEB patients as recurrent mutations at
hypermutable CpG sites (Kivirikko et al., 1996). Nevertheless, the
pathogenicity of these variants in AI remains to be confirmed
since segregation of one of the variants with the dental phenotype
was inconsistent, and for the other, no segregation was possible,
since only one affected individual was recruited to the study.
COL17A1 mutation carriers with an AI phenotype harbor
glycine substitutions, as well as nonsense, frameshift and splicing
mutations (McGrath et al., 1996; Murrell et al., 2007). The
nonsense and frameshift mutations identified would be expected
to lead to NMD, suggesting that the cause of the phenotype
is haploinsufficiency. The glycine substitutions are predicted
to disrupt an extracellular collagenous triple helix, potentially
affecting both the susceptibility of the protein to degradation and
its secretion (McGrath et al., 1996).
No patients with AI and heterozygous LAMC2 mutations
have yet been reported although it seems likely that these exist.
In addition, other genes which are known to be involved in
the etiology of JEB, such as integrin, alpha 6 (MIM ∗147556)
(Ruzzi et al., 1997) and integrin, beta 4 (MIM ∗147557) (Vidal
et al., 1995), may harbor heterozygous mutations that cause
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dental defects in the absence of skin blistering since homozygous
patients with a number of different JEB sub-types present with
enamel hypoplasia (Fine et al., 2008).
AMTN
Amelotin (AMTN;MIM ∗610912) is a proline, leucine, threonine
and glutamine rich protein secreted by transition andmaturation
stage ameloblasts (Iwasaki et al., 2005; Moffatt et al., 2006). The
protein localizes to the ameloblast basal lamina where it known
to bind to itself, to ODAM (odontogenic, ameloblast associated)
and to SCPPPQ1 (secretory calcium-binding phosphoproteins
proline-glutamine rich 1) (Holcroft and Ganss, 2011; Fouillen
et al., 2017). It is hypothesized to form large aggregates (Holcroft
and Ganss, 2011; Bartlett and Simmer, 2015). These aggregates
are thought to mediate attachment between the maturation stage
ameloblasts and the mineralizing enamel (Moffatt et al., 2014).
AMTN is also expressed at the junctional epithelium, a structure
partially formed frommaturation stage ameloblasts that mediates
the attachment of the gingiva to the tooth (Bosshardt and Lang,
2005; Moffatt et al., 2006).
Murine models of amelotin function include an Amel
promoter driven Amtn overexpressing mouse (pAmel:Amtn+/+)
and a knockout (Amtn−/−) model (Lacruz et al., 2012a;
Nakayama et al., 2015). The pAmel:Amtn+/+ model had thin
brittle enamel with an irregular surface layer (Lacruz et al.,
2012a). The Amtn−/− model had mandibular incisors with a
chalky appearance and enamel in which mineralization was
delayed and organic material retained (Nakayama et al., 2015).
The surface enamel easily chipped away and was found to be
softer than the inner and middle enamel (Nakayama et al., 2015;
Nunez et al., 2015). These phenotypes and an in vitro study
that found that AMTN promotes HA precipitation, suggested
a critical role for AMTN in the formation of compact surface
aprismatic enamel during maturation (Abbarin et al., 2015).
Therefore, AMTN could be bi-functional, with roles in both
cell-matrix attachment and mineral nucleation.
In humans, only one AMTN mutation has been associated
with AI; an in-frame deletion spanning exons 3 to 6 (Smith et al.,
2016). The family exhibited hypomineralized AI with autosomal
dominant inheritance. Phenotypic analysis of teeth revealed that
the enamel was of a lower mineral density when compared to
WT and the typical prismatic enamel structure was disturbed
throughout the enamel layer.
FAM83H
Family with sequence similarity 83, member H (FAM83H; MIM
∗611927), is an intracellular protein with ubiquitous expression
(Lee et al., 2008a). In oral tissues, the ameloblasts show the
highest expression of FAM83H, especially in pre-secretory and
secretory stages (Lee et al., 2008a). Lower expression is seen in
maturation stage ameloblasts as well as in the odontoblasts and
alveolar bone (Lee et al., 2008a).
Through homology, FAM83H was suggested to be involved
in membrane vesicle trafficking or cytoskeletal reorganization
(Foster and Xu, 2003; Ding et al., 2009). FAM83H has now been
shown, via binding to casein kinase 1 (CK1), to regulate the
organization of the keratin cytoskeleton and therefore also to be
involved in desmosome formation (Kuga et al., 2016).
Human mutations identified in FAM83H cause autosomal
dominant hypocalcified AI (MIM #130900) (Mendoza et al.,
2007; Kim et al., 2008). Analysis of teeth from individuals with
FAM83H mutations identified defects in enamel rods, especially
at the DEJ, with increased organic content within the enamel
(El-Sayed et al., 2010; Zhang et al., 2015a).
All of the mutations identified so far have been located in the
final, largest exon and all but two are nonsense or frameshift
variants predicted to lead to premature translation termination
(Kim et al., 2008; Lee et al., 2008a, 2011; Ding et al., 2009; Hart
et al., 2009; Hyun et al., 2009; Wright et al., 2009, 2011; El-Sayed
et al., 2010; Chan et al., 2011). As terminating mutations in the
last exon are generally not subject to NMD (Nagy and Maquat,
1998), the truncated products may cause AI through a dominant
gain of function effect.
In vitro analysis of three of the reported AI-causing FAM83H
mutations suggests that the mutations alter the localization of
the FAM83H protein, leading to an increased concentration
within the nucleus rather than its typical cytoplasmic location
(Lee et al., 2011). Analysis of the shortest of the truncated
mutant proteins reported, p.S287∗ (NP_198488.3), revealed that
it bound and inhibited CK1 (Kuga et al., 2016). All of the
twenty-seven FAM83H mutations identified reside within the
first 1343 bp of the final exon (up to Glu694) with the final
1460 bp devoid of known mutations, suggesting that this region
may not be critical to FAM83H function. In addition, some
degree of phenotypic variation has been reported in patients,
with mutations predicted to produce longer truncation products
having a milder phenotype confined to just the cervical areas of
the teeth (Wright et al., 2009).
Interestingly, Fam83h knockout mice and a mouse
overexpressing FAM83H do not show an AI enamel phenotype
(Kweon et al., 2013) supporting a dominant negative effect as the
disease mechanism.
Transport
The formation of enamel requires both the transport of large
volumes of protein from ameloblasts via exocytic vesicles
during the secretory stage and the removal of degraded protein
via endocytic pathways during the maturation stage. During
maturation, ameloblasts must also increase the active transport of
mineral ions into the enamel space to support crystallite growth.
Efficient and effective transport of cellular cargo is therefore
critical in enamel formation.
WDR72
WD repeat domain 72 (WDR72; MIM ∗613214) is believed to
form a beta propeller structure (Jawad and Paoli, 2002; Valeyev
et al., 2008) and is predicted by protein homology to be an
intracellular vesicle coat protein (El-Sayed et al., 2009; Katsura
et al., 2014). WDR72 expression is widespread, and is highest
in bladder and kidney (Lee et al., 2010b). Immunolocalization
of WDR72 in mouse incisors revealed more intense staining in
maturation stage than secretory stage ameloblasts (El-Sayed et al.,
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2009), with a specific increase in expression noted to occur at the
initiation of enamel maturation (Katsura et al., 2014).
Wdr72 null mouse models exhibit hypomaturation AI
(Katsura et al., 2014;Wang et al., 2015). In onemodel, maturation
stage ameloblasts were shorter compared withWTmice, whereas
there was no difference for secretory stage ameloblasts (Katsura
et al., 2014). Affected enamel appeared stained and opaque
and had retained proteins within it, including amelogenin. In
another null mouse model, attachment between the ameloblasts
and the enamel matrix was found to be disrupted (Wang et al.,
2015). Ruﬄe ended maturation stage ameloblasts, thought to be
responsible for protein removal, did not appear to be present and
uptake of processed enamel matrix proteins by maturation stage
ameloblasts was affected (Wang et al., 2015). In addition, the
localization of putative Ca2+ transporter SLC24A4 was altered in
Wdr72−/− mice.
Originally, three truncatingWDR72mutations were identified
in patients with autosomal recessive hypomaturation AI (MIM
#613211) (El-Sayed et al., 2009). Subsequently, other truncating
mutations have been described, all causing an identical enamel
phenotype and likely to be subject to NMD (Lee et al.,
2010b; Chan et al., 2011; El-Sayed et al., 2011; Wright et al.,
2011; Kuechler et al., 2012; Katsura et al., 2014). Patients
with mutations affecting the region between the two beta
propeller clusters have also been reported to exhibit hypodontia
and delayed tooth eruption (Kuechler et al., 2012; Katsura
et al., 2014). Additionally there have been reports of short
stature in families with WDR72 variants; however, given the
consanguineous nature of themajority of the families studied and
the lack of adequate controls, it is difficult to directly associate the
phenotype with WDR72 variants and to exclude the possibility
that this is caused by an additional co-segregating variant.
SLC24A4
Solute carrier family 24 (Sodium/potassium/calcium exchanger),
member 4 (SLC24A4; MIM ∗609840) is one of a family of
potassium dependent sodium/calcium exchangers. Members
of this protein family share highly conserved hydrophobic
regions, termed alpha-1 and alpha-2 repeats, which interact to
form ion-binding pockets and lie within two clusters of five
transmembrane helices (Iwamoto et al., 2000; Parry et al., 2013).
SLC24A4 is highly expressed in a wide range of tissues including
brain, aorta, lung and thymus (Li et al., 2002). Within the
developing tooth, it is expressed by maturation stage ameloblasts
and localizes to the membrane in contact with the developing
enamel (Hu et al., 2012). In rat, Slc24a4 transcripts are highly
upregulated during the shift from secretion to maturation in
the enamel organ (Lacruz et al., 2012b) and it is suggested that
SLC24A4 is responsible for the active transport of Ca2+ ions
from ameloblasts into the enamel matrix during maturation
(Wang et al., 2014a). In mice, SLC24A4 expression is restricted
to ruﬄe-ended maturation stage ameloblasts (Bronckers et al.,
2015).
Mutations in SLC24A4 cause a hypomaturation/
hypomineralized AI phenotype with autosomal recessive
inheritance (Parry et al., 2013; Seymen et al., 2014; Wang et al.,
2014a; Herzog et al., 2015; Prasad et al., 2016a). Missense
mutations affecting both alpha repeats and the cytoplasmic
domain, as well as a nonsense mutation and a multi-exonic
deletion, have been detected. Subsequent to the identification
of SLC24A4 mutations in human AI, incisors from Slc24a4
null mice (Stephan et al., 2012) were examined using SEM
and a similar phenotype was observed. The enamel was poorly
mineralized and quickly wore away to expose the underlying
dentine (Parry et al., 2013).
Others: pH Sensing, Crystal Nucleation,
and Unknown Functions
Some of the genes known to be mutated in AI have protein
products with functions that cannot be grouped easily. In other
cases, their function is debated or is simply unknown. It is
becoming ever more apparent that discovery of the causative
mutations in AI is only the first step and that experiments to
discover the functions of the encoded proteins through creation
of murine models or in vitro study, will be crucial in the
understanding of amelogenesis and the pathology of AI.
GPR68
G protein-coupled receptor 68 (GPR68; MIM ∗601404) is a
proton-sensing protein known to function in a wide range of cells
including osteoblasts and osteocytes (Ludwig et al., 2003; Yang
et al., 2006). Its activation leads to inositol phosphate formation
and calcium release from intracellular stores (Ludwig et al., 2003).
The protein contains seven transmembrane helices, with the
histidine residues responsible for its pH sensing properties on the
extracellular surface of the protein (Ludwig et al., 2003). GPR68
has been shown to be expressed in ameloblasts throughout all
stages of amelogenesis, with strong expression at the ameloblast
pole in contact with the enamel matrix (Parry et al., 2016). GPR68
activation is known to result in inositol phosphate formation that
is associated with cytoplasmic re-organization and membrane
ruﬄing (Honda et al., 1999; Czech, 2000; Parry et al., 2016).
Therefore, Parry et al. (2016) proposed that GPR68 acts as a pH
sensor in amelogenesis, directing ameloblasts to switch between
the ruﬄe ended and smooth ended conformations during the
maturation stage.
Three families with autosomal recessive hypomineralized AI
have been reported with mutations in the single exon GPR68
gene (MIM #617217) (Parry et al., 2016). All are predicted to
result in loss of function. Two of the families carried deletions
expected to remove histidine residues shown to be crucial to the
pH sensitivity or the structural integrity of the protein. The third
carried a missense variant predicted to destabilize the second
transmembrane helix.
In light of mutations in GPR68 leading to AI in humans,
the incisors of Gpr68−/− mice (Mogi et al., 2009) were assessed
for enamel defects (Parry et al., 2016). A limited phenotype, of
retarded formation of enamel with minor structural differences,
was reported. This phenotype partially mirrorsGRP68-associated
AI in humans but may also reflect temporal differences in human
and murine amelogenesis, the genetic strain of the Gpr68−/−
model or the possibility that mutant protein persists in cases of
human AI.
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C4orf26
The chromosome 4 open reading frame 26 (C4orf26; MIM
∗614829) gene encodes a proline rich protein containing a
signal peptide, two highly conserved but unknown motifs and
ten predicted phosphorylation sites (Parry et al., 2012). It has
been suggested, based on its amino acid sequence, that C4orf26
belongs to the acidic phosphoprotein family of proteins. These
are known to promote HA crystallization, and C4orf26 peptide
with a phosphorylated C-terminus was shown to promote HA
nucleation and support crystal growth in vitro (Parry et al., 2012).
Analysis of C4orf26 expression in rat revealed transcripts in both
secretory and maturation stage enamel organs but not in heart or
kidney, and in a human cDNA panel lacking any dental tissues,
expression was highest in placenta but was also evident in many
other tissues (Parry et al., 2012).
Six mutations have been identified in C4orf26 in ten families
with autosomal recessive hypomineralized AI (MIM #614832)
(Parry et al., 2012; Prasad et al., 2016b). These include only
nonsense, frameshift and splice site variants predicted to escape
NMD. However, the resulting proteins are predicted to be non-
functional. Enamel from affected individuals contained thin
crystallites more typical of the early maturation stage of enamel
development rather than of mature enamel. To date no mouse
model has been characterized.
ACPT
Acid phosphatase, testicular (ACPT; MIM ∗606362) is one
of a group of enzymes capable of hydrolysing esters of
orthophosphoric acid in acidic conditions (Romas et al., 1979). It
is expressed by secretory, but not maturation stage, ameloblasts
(Seymen et al., 2016) and it has been suggested to elicit
odontoblast differentiation and mineralization by supplying
phosphate during dentine formation (Choi et al., 2016). ACPT
was first identified as a gene immediately centromeric to the
kallikrein gene cluster within a region of chromosome 19q13.3-
q13.4 that is differentially expressed in solid tumors (Yousef
et al., 2001). ACPT is itself known to show lower expression
in testicular cancer tissues compared to normal tissues and
is regulated by steroid hormones (Yousef et al., 2001). Its
chromosomal location, around 111 kb proximal to KLK4, is
notable, although Acpt was first associated with amelogenesis
through the differential analysis of ameloblast gene expression in
rats (Lacruz et al., 2011). However, the function of ACPT during
amelogenesis is currently unclear and no mouse model has been
characterized to date.
ACPT is also expressed in the brain, where it is enriched at
post-synaptic sites, and is thought to dephosphorylate the ErbB4
receptor (Fleisig et al., 2004). The ErbB4 receptor has important
roles in neuronal differentiation and synaptogenesis, and ACPT
acts as a tyrosine phosphatase to modulate signals mediated by
ErbB4 that are important for neuronal development and synaptic
plasticity (Fleisig et al., 2004).
Mutations in ACPT were recently identified in eight families
with autosomal recessive hypoplastic AI (MIM #617297)
(Seymen et al., 2016; Smith et al., 2017b). All seven variants
identified are missense changes predicted to affect residues
within the extracellular domain that makes up the majority
(residues 29–390; NP_149059.1) of the 426 amino acid protein.
Assessment of an affected tooth by X-ray computed tomography
revealed that the enamel, where present, was around one tenth
of the thickness of control enamel, but was well mineralized
(Smith et al., 2017b). The authors found that the underlying
dentine was hypermineralized compared to control, although
no abnormalities were evident upon clinical examination (Smith
et al., 2017b). Assessment of additional samples will be required
to confirm this.
Master Controllers of Amelogenesis
These genes control gene expression or the modification of
a subset of AI- and other- proteins to influence enamel
development. Both members of this group are involved in the
development and/or maintenance of other organs and therefore
disease can present as both isolated and syndromic AI, although
enamel symptoms are usually the first to develop and can serve
as an early warning for the development of other pathology.
FAM20A
Family with sequence similarity 20, member A (FAM20A) is one
of a family of three human homologs of the Drosophila four
jointed (fj) protein kinase. Additional family member FAM20C
is a Golgi casein kinase responsible for phosphorylating many
secreted proteins involved in biomineralization (Tagliabracci
et al., 2012). In vitro expression of FAM20A has shown that it
is also located in the Golgi (Ishikawa et al., 2012; Wang et al.,
2013a). FAM20A has been shown to control FAM20C localization
and to potentiate its extracellular action in vitro (Ohyama et al.,
2016). The protein is therefore designated a pseudokinase (Cui
et al., 2015).
Mutations in FAM20A have been shown to cause autosomal
recessive AI and gingival fibromatosis syndrome (AIGFS;
O’Sullivan et al., 2011) and enamel renal syndrome (ERS;
Jaureguiberry et al., 2012; Wang et al., 2013a). Both syndromes
have since been recognized as phenotypic variants of the
same condition and are now collectively termed ERS (MIM
#204690) (de la Dure-Molla et al., 2014). Patients with FAM20A
mutations have hypoplastic AI which, in extreme cases, may
present as a complete absence of enamel (de la Dure-Molla
et al., 2014) or characteristic “glassy” incisor teeth. There are a
variety of associated ERS oral defects that may include delayed
tooth eruption, hyperplastic dental follicles, pulp stones and
gingival overgrowth with ectopic calcification (de la Dure-Molla
et al., 2014). Calcification of other organs, most frequently
nephrocalcinosis, is variably reported. This may be due to a
combination of age, genetic modifiers, and exposure to Ca2+
channel blocking drugs (Poulter et al., 2015).
The symptoms associated with ERS suggest that FAM20A
phosphorylates proteins involved in enamel formation and
other aspects of tooth development, as well as those critical
to Ca2+ regulation within the kidney. Analysis of developing
murine oral tissues showed the presence of FAM20A within
ameloblasts, odontoblasts and at consistently high levels within
the oral epithelium (Wang et al., 2014c). Ameloblasts expressed
FAM20A only during the secretory stage, consistent with the
hypoplastic AI phenotype (Wang et al., 2014c). Analysis of
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teeth from Fam20a−/− mice showed that the ameloblast layer
was disorganized and detached from the DEJ, leading to pitted
and thin enamel (Vogel et al., 2012). A similar phenotype was
observed in an epithelial specific (K14-cre) Fam20a−/− model,
along with reduced levels of ENAM and MMP20 proteins in
ameloblasts but increased levels of AMBN (Li et al., 2016). The
authors suggest that reduced levels of ENAMmay be due to a lack
of phosphorylation by FAM20C due to the absence of FAM20A.
However, the authors do not explain the increased and decreased
levels of AMBN and MMP20, respectively.
DLX3
Distal-less homeobox 3 (DLX3; MIM ∗600525) is one of a family
of six DLX transcription factors essential to the development
of placental, epidermal and ectodermal appendages (Beanan
and Sargent, 2000). DLX3 is also expressed in skin, bone and
dental tissues including both the odontoblasts and ameloblasts,
with greatest expression in ameloblasts during the late secretory
stage (Zhang et al., 2015b). Murine whisker and hair follicles
strongly express DLX3 before birth but expression decreases after
birth. DLX3 is expressed in the placenta during early embryonic
development and Dlx3−/− mice die around embryonic day
10 due to placental defects, whereas Dlx3+/− mice appear
phenotypically normal (Morasso et al., 1999). Although, the role
of DLX3 has been studied in dentine, bone and hair, through the
creation of conditional knockouts of Dlx3, (Hwang et al., 2008;
Duverger et al., 2012, 2013) no study has reported the creation of
a conditional knockout of Dlx3 in ameloblasts.
Mutations in DLX3 are known to cause the autosomal
dominantly-inherited trichodentoosseous syndrome (TDO;
MIM #190320) and amelogenesis imperfecta hypomaturation-
hypoplastic type with taurodontism (AIHHT; MIM #104510).
TDO is defined as AIHHT with additional features such as kinky
hair, especially in infancy, and increased bone density/thickening
of the craniofacial cortical bones (Lichtenstein and Warson,
1971). Other variably associated features include flattened
fingernails and altered craniofacial morphology, including
dolichocephaly and prognathism (Price et al., 1998).
A mutation was first associated with AIHHT in patients
carrying a 2 bp deletion (c.561_562delCT; NM_005220.2) in
DLX3 (Dong et al., 2005). Other families of different ethnicities
have since been described with the same DLX3 mutation,
potentially highlighting the position as a mutational hotspot.
However, the phenotype varies from AI with only mild
taurodontism (Kim et al., 2016a) to TDO (Lee et al., 2008b)
suggesting that there may be wide phenotypic variation in
presentation, even for identical DLX3mutations.
DLX3, like all DLX proteins, contains a homeobox domain
flanked by N- and C-terminal transactivation domains. The
homeobox domain directly binds to target DNA sequences but
the transactivation domains have also been shown to be crucial
to this binding. DLX3 has been shown to bind to the enhancer
regions of Amelx, Enam and Odam in a murine ameloblast cell
lineage and to positively regulate their expression (Zhang et al.,
2015b).
Only six DLX3 variants have been reported so far, including
two frameshift variants predicted to escape NMD but to result in
an altered C-terminal transactivation domain and four missense
variants predicted to affect residues (spanning residues 133–182;
NP_005211.1) within the central DNA binding homeodomain
(residues 129–188). Disease has been postulated to result from
haploinsufficiency (Nieminen et al., 2011) but other effects,
including dominant negative through binding to WT DLX3
(Duverger et al., 2008), as well as gain of function, through
interactions of the mutant protein with other transcription
factors, have not been ruled out.
Frequency of Mutations Identified in AI
Cohorts
Given the paucity of epidemiological data on AI, the difficulty in
estimating its prevalence and the recent advances in knowledge
of the underlying genetic causes, we assessed the frequencies of
variants in each gene recorded in the AI Leiden Open Variant
Database (LOVD) resource (http://dna2.leeds.ac.uk/LOVD/).
These findings are biased by studies focusing on particular
populations or the specific recruitment of consanguineous
families with recessively inherited AI for ease of study. The
targeted sequencing of AI cohorts for variants in particular genes
and the time since discovery of causality of each of the AI
genes will also influence reported relative contributions to disease
burden. It is also likely that variants that cause AI as a dominant
trait but JEB as a recessive trait, i.e. those in LAMA3, COL17A1,
and potentially also LAMB3, are underreported. JEB carriers
are often only mentioned in passing in reports as having poor
enamel. A larger AI-focused study of carriers of LAMA3, LAMB3,
and COL17A1 variants would help to clarify the frequency of
enamel defects in these individuals andwhether the same variants
cause both isolated AI and JEB in the case of LAMB3 variants.
However, with all of these caveats, as of 23rd May 2017, the
AI LOVD resource (http://dna2.leeds.ac.uk/LOVD/) details 192
different, published AI gene variants identified in 270 families
with AI (Table 1). Analysis of these variants shows that just four
genes account for the cause of AI in 163 families (60.4%). Variants
were most commonly identified in FAM83H (19.3% of cases),
followed by FAM20A (15.2%), ENAM (14.2%), and AMELX
(11.5%). Of the AI families reported with a known mutation, 132
(48.9%) have autosomal dominant AI, with autosomal recessive
(109 families; 40.4%) and X linked inheritance (31 families;
11.5%) less frequently reported.
Analysis has also shown that there are a number of variants
that have been repeatedly identified in families with AI and
that may represent founder mutations or reside at mutational
hotspots. These include ENAM c.92T>G, p.(L31R) (Brookes
et al., 2017) and KLK4 c.632delT, p.(L211Rfs∗37) (Smith et al.,
2017a). Some genes, for example FAM83H and WDR72, show
clear trends in the types and positions of AI-causing variants
reported, giving clues as to how these variants cause disease.
From a recent focused clinical exome study, molecular
diagnoses were obtained in only 18 of 65 syndromic and non-
syndromic AI cases (27.7%) (Prasad et al., 2016a). Earlier studies
using Sanger sequencing of candidate genes identified variants in
36.6–48.7% of families (Chan et al., 2011; Wright et al., 2011).
This suggests that additional AI genes remain to be identified
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FIGURE 4 | The three “compartments” involved in amelogenesis: the enamel space (extracellular matrix; red), the enamel organ (ameloblast cell layer and supporting
cells; blue) and the interface between the two (purple). Known AI proteins are grouped according to functions within compartments. Those with no causative
mutations for AI identified are designated by square brackets.
and/or that variants in known AI genes, such as intronic,
regulatory, and larger structural alterations, are being missed by
current analysis pipelines. For example, particular variant types,
such as heterozygous copy number changes larger than an exon,
are likely to be under-represented in reports since they would not
have been identified by Sanger sequencing or WES data without
specific downstream analysis (Poulter et al., 2015; Smith et al.,
2016).
DISCUSSION
This article reviews the genes and proteins where variants
cause AI presenting in isolation of other health problems and
also reviews current knowledge of their functions. Potential
mechanisms of disease were explored with reference to evidence
from mouse models and human pathology. Finally, the
prevalence of reports of families with AI with mutations in each
gene was explored through the development and interrogation of
an AI LOVD resource.
It is evident that some proteins with roles in amelogenesis
can be classified into clear functional groups, with obvious
examples including the EMPs: AMELX, ENAM and AMBN; the
enamel matrix proteases: MMP20 and KLK4; as well as those
involved in cell-cell and cell-matrix adhesion: ITGB6, LAMB3,
LAMA3, COL17A1, AMTN, and FAM83H, transport: WDR72
and SLC24A4 and master controllers of amelogenesis: FAM20A
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and DLX3. However, there is also an emerging group of proteins
that exhibit diverse functions in enamel development. These
include proteins thought to be involved in activities as wide-
ranging as crystal nucleation (C4orf26), proton sensing (GPR68)
and those with unknown roles (ACPT). Further investigation
is required to define the role of each protein in amelogenesis
and to identify interacting partners, mechanisms, and functional
pathways.
To understand the events of amelogenesis and how mutations
can impact on the enamel formed, it is important to consider
three linked but distinct compartments, namely the cellular
enamel organ, including both the ameloblast cell layer and its
supporting cells, the extracellular enamel space and the interface
between sites (Figure 4). Initial mutation discovery focused on
EMPs and the events in the extracellular enamel space. However,
it is becoming clear that intracellular events in the ameloblast,
ameloblast cell-cell interactions and ameloblast attachment to
the enamel matrix also play critical roles in amelogenesis.
Even disease previously considered to be entirely the result of
perturbations in extracellular events, such as that resulting from
EMP mutations, has, in some cases, been shown to result in
catastrophic intracellular effects. For example, somemutations in
Amelx (Barron et al., 2010) and Enam (Brookes et al., 2017) lead
to activation of the unfolded protein response and to apoptosis
of ameloblasts. Therefore, it is important to consider pathology
in the context of all three compartments and to study the roles of
the affected proteins through the production of murine models
with AI specific mutations. Assessment of the variants identified
in human AI to date suggests that for many AI genes, trends
indicate that protein absence may not be the mechanism of
disease.
Classification of AI by phenotype and pattern of Mendelian
inheritance has been modified since the first description of
AI as a separate condition to dentinogenesis imperfecta in
1938 (Finn, 1938; Aldred et al., 2003). In recent years, the
narrow definition of AI as an isolated enamel pathology
has expanded to include diverse syndromes with generalized
developmental enamel defects indistinguishable from AI in
isolation (Aldred et al., 2003). The ability to identify the
underlying genetic cause in individuals with AI has informed
a more meaningful classification. Nevertheless, recognition of
characteristic phenotypes remains useful. For example, patients
with FAM20A variants can be readily identified upon oral
examination. Patients with FAM20A variants should be referred
for specialist renal evaluation and follow-up, to better understand
the natural history of this feature and for development
of intervention strategies to limit development of ectopic
calcification. The contribution of this gene to the variant load
reported for AI, described in the LOVD resource, is 15.2%.
Therefore, FAM20A variants are the second most commonly
reported cause of AI overall and the most commonly reported
cause for autosomal recessive AI, at least in the AI LOVD
of published reports. This finding highlights the real need for
genetic diagnosis for AI patients. Knowledge of AI genetics has
already prompted the development of a targeted diagnostic AI
genetic screen within the UK National Healthcare Service that
will help to inform improved patient pathways and to raise
standards of care (Holland, 2017).
WES has expedited the identification of new genetic variants
that cause AI (O’Sullivan et al., 2011; Jaureguiberry et al., 2012;
Poulter et al., 2014a,b) but it is likely that more genes, not
currently known to be critical for enamel formation, remain to
be identified. As costs continue to fall, whole genome sequencing
is also facilitating the discovery of mutations that cannot be
found by conventional WES analysis (Poulter et al., 2015). For
many human conditions, greater awareness of the importance
of non-coding mutations is leading to an increase in the study
of patient mRNA. However, for AI this approach is hampered
by the enamel specific expression of many of the genes so
far implicated. Transcript profiling in mammalian models can
overcome this difficulty and highlight potential candidate genes,
such as SLC24A4, where genetic variants were subsequently
confirmed as causing of AI (Lacruz et al., 2012b).
The identification of AI genes will allow clinical andmolecular
diagnoses to be matched. This will in turn help clinicians to
improve patient pathways and offer a more accurate prognosis
and clearer risk information to patients and other family
members. Genotyping of AI cohorts will facilitate participant
recruitment to future clinical trials to develop improved
clinical decision-making for AI, consistent with an increasingly
personalized precision approach to care. To further support the
development of diagnostic screening and variant interpretation
in AI, we have created a dedicated LOVD resource recording
all published mutations causing AI presenting in the absence
of other health problems (http://dna2.leeds.ac.uk/LOVD/). The
improved understanding of AI resulting from identification of
the causative mutations and their pathogenesis also highlights
new avenues for possible therapeutic intervention to improve
outcomes for those with AI. ER stress is now recognized as
a mechanism of AI pathogenesis (Brookes et al., 2014, 2017)
and represents a possible therapeutic opportunity through in
utero/early post-natal use of protein chaperoning/anti-apoptotic
drugs such as 4-phenylbutyrate (Brookes et al., 2014). Biomimetic
technologies that repair carious lesions to enamel have also
been reported (Brunton et al., 2013) although it remains to
be seen whether these will be effective in treating selective
forms of AI. A thorough understanding of the molecular
mechanisms underlying biomineralization, obtained through a
genetic dissection of AI, will inform the development of new
interventions for enamel defects.
In summary, recent increases in our understanding of the
genetic variants that cause AI offer us new insights into the varied
cellular and extracellular biological processes that are essential
for enamel formation. Collation of published genetic variants
causing AI presenting in the absence of other health problems
in one LOVD resource will support this process. New genetic
insight can translate into improved patient care in the short-term
and will inform the development of new therapeutic strategies for
enamel pathologies that are not expected to be restricted to AI in
the future.
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